Non-Hodgkin's Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma
Condition: CD20-positive B-cell Non-Hodgkin's Lymphoma Intervention: Drug: IMM0306 Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2023 Category: Research Source Type: clinical trials
